Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial update describing a study comparing treatment given before versus after surgery in patients with resectable stage II …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) [Phase 1]
Phase 1 study of ADP-A2M4CD8 as monotherapy or in combination with nivolumab or pembrolizumab in HLA-A2+ patients with MAGE-A4-positive tumo…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for PF-08046052/SGN-EGFRd2 in advanced solid tumors, including colorectal cancer, non-small cell lung cancer, …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201) [Phase 2]
This update covers a Phase 2 study (MTAPESTRY 201) of Anvumetostat in MTAP-deleted advanced non-small cell lung cancer, and the trial is cur…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors [Phase 1]
Pfizer's Phase 1 study PF-08046876 is recruiting adults with various advanced solid tumors to evaluate safety and dosing. The trial includes…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 [Phase 2]
Update on a Phase 2 study of disitamab vedotin in HER2-expressing solid tumors, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors [Phase 1]
FT836 is being studied in a Phase 1 trial for advanced solid tumors, administered with or without chemotherapy and/or monoclonal antibodies.…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC or Other ALK+ Solid Tumors
This update announces the availability of an Expanded Access Program for Neladalkib (NVL-655) for patients with advanced ALK-positive non-sm…
-
CLINICAL_TRIALS other · 2026-04-07Clinical Trial Update: Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC
This clinical trial update reports on the planned evaluation of SHR-A1811 for effectiveness and safety in Chinese patients with HER2-altered…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Real-world Association Between Concomitant Beta-blocker Exposure and Anti-PD-1/PD-L1 Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
A completed real-world study assesses whether concurrent beta-blocker use affects outcomes for patients with advanced non-small cell lung ca…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI [Phase 3]
Phase 3 clinical trial update evaluating adaptive hypofractionated radiotherapy guided by dynamic enhanced MRI for locally advanced non-smal…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment [Phase 3]
An active Phase 3 trial is evaluating Savolitinib in combination with Osimertinib versus platinum-based chemotherapy in patients with non-sm…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer [Phase 1]
A Phase 1 study assessing RAD001 (everolimus) in combination with radiotherapy for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases [NA]
Clinical trial update on a Gallium-68 labeled PSMA PET/CT tracer being studied to differentiate radiation necrosis from tumor progression in…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
This clinical trial update reports real-world outcomes for ALK-positive early-stage non-small cell lung cancer patients treated with adjuvan…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating maintenance olaparib in platinum-sensitive advanced non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study [Phase 2]
This clinical trial update reports on a Phase 2 NORTHSTAR study evaluating osimertinib in combination with surgery and radiation therapy for…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 1]
An update on a Phase 1b trial evaluating datopotamab deruxtecan (Dato-DXd) in combination with immunotherapy, with or without carboplatin, f…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients [Phase 2]
Ongoing Phase 2 neoadjuvant trial evaluating cemiplimab for resectable non-small cell lung cancer, hepatocellular carcinoma, and head and ne…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201) [Phase 3]
A Phase 3 clinical trial comparing Pumitamig to Durvalumab after concurrent chemoradiation in unresectable stage III non-small cell lung can…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer [Phase 1]
Phase 1 clinical trial evaluating autologous T-cells engineered to target KRAS mutations in combination with a KRAS-directed vaccine for met…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy [NA]
A clinical trial update comparing single-dose versus multiple-dose radiation in cancer patients with brain metastases who are receiving immu…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1 [Phase 1, Phase 2]
A Phase 1/2 trial evaluating ChAdOx1 and MVA vaccines targeting MAGE-A3 and NY-ESO-1 for non-small cell lung cancer and esophageal squamous …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer [Phase 2]
This clinical trial update indicates a Phase 2 study evaluating defactinib, avutometinib, and nivolumab for anti-PD-1 refractory LKB1-mutant…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating NBTXR3 with radiation therapy alone for locally advanced non-small cell lung cancer. The stud…